Axogen (AXGN) Non-Current Debt (2011 - 2025)
Axogen's (AXGN) quarterly Non-Current Debt came in at $48.4 million in Q4 2025, up 1.88% year-on-year from $47.5 million in Q4 2024, and little changed quarter-over-quarter from $48.2 million in Q3 2025.
Axogen (AXGN) Non-Current Debt (2011 - 2025) Analysis & Trends
Axogen's Non-Current Debt history runs 15 years deep, the most recent figure standing at $48.4 million for Q4 2025.
- On a quarterly basis, Non-Current Debt rose 1.88% year-over-year to $48.4 million in Q4 2025; TTM through Dec 2025 was $48.4 million, a 1.88% increase from a year earlier, with the FY2025 full-year figure at $48.4 million, up 1.88% from the prior year.
- Non-Current Debt steadied at $48.4 million in Q4 2025 per AXGN's latest filing, from $48.2 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $48.4 million in Q4 2025 and bottomed at $32.1 million in Q1 2021.
- The 5-year median for Non-Current Debt is $46.3 million (2021), against an average of $45.8 million.
- Across the five-year window, Non-Current Debt jumped 2603.11% in 2021 and slipped 1.78% in 2022, its largest moves.
- Year by year, Non-Current Debt stood at $44.8 million in 2021, then grew by 1.99% to $45.7 million in 2022, then grew by 1.95% to $46.6 million in 2023, then advanced by 1.92% to $47.5 million in 2024, then grew by 1.88% to $48.4 million in 2025.
- Per Business Quant, the three latest AXGN Non-Current Debt figures stand at $48.4 million (Q4 2025), $48.2 million (Q3 2025), and $47.9 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48.39 Mn |
| Sep 30, 2025 | 48.16 Mn |
| Jun 30, 2025 | 47.94 Mn |
| Mar 31, 2025 | 47.72 Mn |
| Dec 31, 2024 | 47.50 Mn |
| Sep 30, 2024 | 47.27 Mn |
| Jun 30, 2024 | 47.05 Mn |
| Mar 31, 2024 | 46.83 Mn |
| Dec 31, 2023 | 46.60 Mn |
| Sep 30, 2023 | 46.38 Mn |
| Jun 30, 2023 | 46.15 Mn |
| Mar 31, 2023 | 45.93 Mn |
| Dec 31, 2022 | 45.71 Mn |
| Sep 30, 2022 | 45.49 Mn |
| Jun 30, 2022 | 45.26 Mn |
| Mar 31, 2022 | 45.04 Mn |
| Dec 31, 2021 | 44.82 Mn |
| Sep 30, 2021 | 46.24 Mn |
| Jun 30, 2021 | 46.08 Mn |
| Mar 31, 2021 | 32.14 Mn |